Recruitment

Recruitment Status
Terminated

Exclusion Criteria

refusal to provide informed consent or inability to follow up
prior history of ipsilateral DVT or femoral catheters
indications for thrombolytic therapy (i.e. phlegmasia cerulean dolens)
...
refusal to provide informed consent or inability to follow up
prior history of ipsilateral DVT or femoral catheters
indications for thrombolytic therapy (i.e. phlegmasia cerulean dolens)
life expectancy < 6 months
pregnancy
the lesion cannot be accessed with the wire guide
allergy to contrast media
severe kidney disease (creatinine clearance < 30 mL min)

Summary

Conditions
  • Deep Vein Thrombosis
  • Venous Thromboembolism
Type
Interventional
Phase
Phase 2
Design
  • Allocation: N/A
  • Intervention Model: Single Group Assignment
  • Masking: None (Open Label)
  • Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Exclusion Criteria

refusal to provide informed consent or inability to follow up
prior history of ipsilateral DVT or femoral catheters
indications for thrombolytic therapy (i.e. phlegmasia cerulean dolens)
...
refusal to provide informed consent or inability to follow up
prior history of ipsilateral DVT or femoral catheters
indications for thrombolytic therapy (i.e. phlegmasia cerulean dolens)
life expectancy < 6 months
pregnancy
the lesion cannot be accessed with the wire guide
allergy to contrast media
severe kidney disease (creatinine clearance < 30 mL min)

Tracking Information

NCT #
NCT02066597
Collaborators
Not Provided
Investigators
  • Principal Investigator: Esteban Gandara, MD OHRI
  • Esteban Gandara, MD OHRI